STMH (Stem Holdings) Research & Development: $0.00 Mil (TTM As of Sep. 2023)


STMH Stem Holdings Inc STMH
12 GF Score
Price $0.00
View Full Analysis

What is Stem Holdings Research & Development?

Stem Holdings STMH -99.00% 12 Research & Development is $0.00 Mil as of Sep. 2023. GuruFocus rates STMH with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Stem Holdings's Research & Development for the three months ended in Sep. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Stem Holdings  (OTCPK:STMH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Stem Holdings Research & Development Related Terms

Stem Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Stem Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Holdings Research & Development Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STMH
12GF Score
Stem Holdings Inc STMH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stem Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Stem Holdings (STMH) has a Research & Development of $0.00 Mil as of Sep. 2023. Research and development expense is the total cost for research and development activities. View historical data on Stem Holdings and its competitors.
Is Stem Holdings' Research & Development too high?
Stem Holdings' current Research & Development is $0.00 Mil. Overall, Stem Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Stem Holdings' Research & Development compare to NXEN and VFRM?
Stem Holdings' Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Stem Holdings and its competitors. Stem Holdings's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Holdings stock overvalued right now?
Stem Holdings (STMH) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Stem Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Stem Holdings (STMH), the current Research & Development is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stem Holdings Business Description

Address 2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
12GF Score

Get the complete analysis for STMH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price